A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of duloxetine 60 mg once
daily to placebo on depression in elderly patients (greater than or equal to 65 years of
age). Patients who do not respond in the first 13 weeks will be eligible for rescue using
pre-defined criteria. Patients randomized to duloxetine 60 mg/day meeting the rescue criteria
will be increased to 120 mg/day. Patients randomized to the placebo arm meeting the rescue
criteria will be assigned to duloxetine 60 mg/day.